Medication info
Newglia Tablets (Choline Alphoscerate)

Newglia Tablets (Choline Alphoscerate)

Prescription medicationTabletOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Pale yellow oval film-coated tablets
Packaging
90 tablets (10 tablets/PTP × 9), 30 tablets/bottle, 90 tablets/bottle
Approval status
Active

MFDS item code 201803136 · Approved 2018.07.30 · Insurance code 644914700

Summary

Main use
Improvement of cerebrovascular insufficiency and organic brain syndrome (memory impairment, confusion, etc.)
Who takes it
Adults
Adult dose
Administer 400mg of choline alfoscerate orally per dose, 2-3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of cerebrovascular insufficiency and organic brain syndrome (memory impairment, confusion, etc.)

  • Memory impairment
  • confusion
  • directional sense disorder
  • reduced motivation
  • decreased spontaneity
  • reduced concentration
View approved original text

This medication is used for secondary symptoms caused by cerebrovascular deficits and degenerative or organic brain syndromes. Specifically, it helps improve symptoms of directional sense disturbances and concentration reduction due to decreased memory, confusion, reduced motivation, and spontaneity. These effects have been confirmed in clinical trials conducted in this country. Therefore, it is used as an effective treatment for the improvement of these symptoms.

How to take

Adult dose

Administer 400mg of choline alfoscerate orally per dose, 2-3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used in patients allergic to this drug or its components. Additionally, it is safer for women who are pregnant or may become pregnant not to take this medication. When taking this medication, symptoms such as nausea may occur; in such cases, the dose of the medication should be reduced. Caution should be taken as it may cause gastrointestinal issues such as gastritis or gastrointestinal diseases. Also, abnormal responses in the nervous system may occur, such as drowsiness, insomnia, irritability, nervousness, seizures, or excessive movement. This medication must be stored in a safe place out of reach of children. Furthermore, transferring this medication to another container may cause accidents or reduce the quality of the drug, so it must be stored in its original container.

Side effects

  • nausea
  • gastritis
  • gastric disorder
  • drowsiness
  • insomnia
  • irritability
  • nervousness
  • seizures
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pale yellow oval film-coated tablets

Package unit

90 tablets (10 tablets/PTP × 9), 30 tablets/bottle, 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.